Douglas Scott Wieland

Luxtera, Inc. engages in the development and delivery of silicon complementary metal-oxide-semiconductor (CMOS) photonics. Its CMOS technology provides bandwidth for applications ranging from local area network to chip-to-chip interconnect. The company was founded by Alex Dickinson, Axel Scherer, Eli Yablonovitch and Lawrence Cary Gunn III in 2001 and is headquartered in Carlsbad, CA.

Part of KKR & Co., Inc., KKR Management LLC is a company that provides investment advisory services. The company is based in New York, NY. The company was founded by George Rosenberg Roberts. George Rosenberg Roberts has been the CEO since incorporation.

Thesan Pharmaceuticals, Inc. provides novel therapeutics for disorders of the skin. The company focuses on the discovery and development of new chemical entities that provide improved treatment options to patients. Thesan Pharmaceuticals was founded in 2011 by Edward P. Monaghan and is headquartered in Carlsbad, CA.

Kohlberg Kravis Roberts & Co. LP (KKR) is a private equity subsidiary of KKR & Co. Inc founded in 1976 by Henry Kravis, George Roberts and Jerome Kohlberg. The firm is headquartered in New York.

Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA.

Part of ICON plc, International Medical Technical Consultants LLC is a company that manages clinical trials. The company is based in Kansas City, MO. International Medical Technical Consultants was acquired by PRA Health Sciences, Inc., part of ICON plc from July 01, 2021 on February 26, 1997.

EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA.

Helixis, Inc. develops a molecular diagnostic testing platform for use in diverse physical locations. The company was founded in 2007 by David Baltimore, Alex Dickinson, Matthew Johnston, George Maltezos & Axel Scherer and is headquartered in Carlsbad, CA.

Part of Roche Holding AG, Boehringer Mannheim Diagnostics Corp. develops and manufactures personal diagnostic devices. The company is based in Houston, TX.

Mipharm SpA manufactures specialty pharmaceuticals and generic drugs. It operates as a third party manufacturing site for various pharmaceutical brands as well as offers integrated services such as packagaing, research, and development. The company was founded by Giuseppe G. Miglio in January 1998 and is headquartered in Milan, Italy.

Lenexa Chamber of Commerce operates as a non-profit organization. The company is headquartered Lenexa, KS.

MergerTech Capital Management LLC (MergerTech Capital) is a venture capital firm founded in 2011 by Nitin Kanna and Karan Kanna. The firm is headquartered in Emeryville, California.

Aeon Scientific AG engages in the development of medical devices for cardiac interventions. Its product supports electro physiologists during ablation procedures, such as for the treatment of Atrial Fibrillation. The technology is a platform with additional potential in other medical applications such as for gastroenterology, neurosurgery and targeted drug delivery in general. The company was founded by Dominik J. Bell in October 2010 and is headquartered in Zurich, Switzerland.

Quantapore, Inc. develops nanopore based nucleic acid sequencing technology products. The firm's proprietary DNA sequencing technology is based on an optically labeled nanopore which interacts via energy transfer with a labeled nucleic acid sample. The company was founded by Martin Huber and Sascha C. Dennstedt in 2009 and is headquartered in Menlo Park, CA.

ChromaCode, Inc. develops software and manufactures laboratory instruments. It uses digital signal processing to improve clinical molecular analysis. The company was founded by Aditya Rajagopal, Alexander G. Dickinson, Axel Scherer, and Gregory J. Gosch in 2012 and is headquartered in Carlsbad, CA.

Gencove, Inc. helps companies, developers and researchers start and manage genomic R&D projects. The company was founded by Tomaz Berisa, Joseph Pickrell, and Kaja Wasik in 2015 and is headquartered in New York, NY.

Trilogy Medwaste, Inc. operates as a hospital & health care waste management company with the tools and services. It services include medical waste, document destruction, sharps disposal, mail back programs, compliance training and birds eye healthcare. The company was founded in 2017 and is headquartered in Houston, TX.

Blue Sprig Pediatrics, Inc. engages in the provision of applied behavior analysis (ABA) therapy services to children with autism spectrum disorder (ASD). It offers focused ABA treatment, comprehensive ABA treatment, and caregiver support services. The company was founded in 2017 and is headquartered in Houston, TX.

Headlands Research, Inc. engages in the provision of clinical research services. Its therapeutic areas include allergy, cardiovascular, dermatology, emergency medicine, immunology, internal medicine, nephrology, neurology, obstetrics and gynecology, pediatrics, physical medicine and rehabilitation, urology, and vaccine. The company was founded by Mark Blumling in 2018 and is headquartered in Corte Madera, CA.

Veranex, Inc. is a tech-enabled service provider that offers a comprehensive platform for the medtech industry. The company is based in Raleigh, NC and has subsidiaries in Sweden, Switzerland, United States, and United Kingdom. The company provides expert guidance for engineering and design, clinical, market access, and regulatory services, enabling accelerated speed to market, controlled development costs, and development risk mitigation. Veranex's holistic approach ensures that all key functional areas are addressed with the highest level of expertise and attention to detail, making it a trusted partner for companies of all sizes. The company was founded in 2021, and Patrick K. Donnelly has been the CEO of the company since 2021.

Part of Sapphiros, BioCrucible Ltd. is a British company that develops high-performance molecular consumer diagnostics. The company is based in Cambridge, UK. BioCrucible is developing next-generation diagnostics based upon breakthrough advances in biomolecular condensate formation. The company aims to develop proprietary molecular detection technologies deploying ultra-rapid isothermal nucleic acid amplification that enable near-patient and at-home testing for infectious disease or genetic indications. The company was founded in 2018 by Niall Antony Armes. Per Grufman has been the CEO of the company since January 20, 2023. BioCrucible was acquired by Sapphiros on July 21, 2021.

Sapphiros is a privately held consumer diagnostics platform company that invests in growth-stage diagnostic companies. Sapphiros is based in Boston, MA and has subsidiaries in the United Kingdom. The company aims to bridge the gap between present and future by focusing on innovative, patient-centric technologies. Sapphiros' portfolio of capabilities and technologies includes novel sample collection, next generation diagnostics, computational biology, and printed electronics, which help consumers access important diagnostic results quickly. The company empowers exceptional entrepreneurs with the full strength of the platform's resources, capital, and expertise to accelerate and enhance growth and impact. The company was founded by Niall Antony Armes and Namal Nawana. Mark Gladwell has been the CEO of the company since 2021.

Lusaris Therapeutics, Inc. is a biotechnology company that focuses on developing next-generation serotonergic neuroplastogen therapeutics to treat severe neuropsychiatric and neurological disorders. The company is based in Boston, MA. The company's lead program, LSR-1019, is a proprietary sublingual formulation of 5-MeO-DMT, a rapidly acting and rapidly clearing serotonergic psychedelic, which is being developed to treat treatment-resistant depression and other neuropsychiatric conditions. The company's pipeline also includes novel neuroplastogens for a wide range of neuropsychiatric and neurological conditions, including migraine and cluster headache. The CEO of the company is Andrew D. Levin.

Synthetica Bio, Inc. is a company that specializes in generative AI for biopharma. The company is based in Anaheim, CA. The company's solution empowers clinical and commercial teams with actionable knowledge in real time. The company was founded by Simon Arkell, Alexander G. Dickinson. Simon Arkell has been the CEO since incorporation.

TZ Holdings LP operates as a pre-packaged software business. The company is headquartered in New York, NY.